title: The role of SRC kinase in the caspase-1 pathway after hypoxia in the brain of newborn piglets.
abstract: Hypoxia induces a cerebral inflammatory response, which contributes to brain injury. Inflammasomes are complex intracellular molecular structures that initiate the inflammatory cascade. Caspase-1 and interleukin 1-β (IL-1β), have been established as markers of inflammasome activation. Src kinase, a cytosolic non-receptor protein tyrosine kinase, is linked to cell proliferation and differentiation and is up regulated during hypoxia. The role of Src kinase in the above pathway is not fully understood. The present study tests the hypothesis that inhibition of Src kinase, by a selective inhibitor, PP2, will prevent the activation of caspase-1 and production of IL-1β acutely, as well as at 1 and 15 days after hypoxia in the cerebral cortex of the newborn piglet. Piglets were divided into: Normoxia (Nx), Hypoxia acute (Hx), Hypoxia-day 1 (Hx-day 1), and Hypoxia day 15 (Hx-day 15). Piglets pretreated with Src kinase inhibitor, PP2, 1 mg/kg IV, 30 min prior to hypoxia were divided into: Hypoxia acute (Hx + PP2), 1 day (Hx + PP2-day 1), and day 15 (Hx + PP2-day 15). Hypoxia was induced by exposing the piglets to an FiO2 of 0.07 for 1 hour. Caspase-1 activity and expression were determined with spectrophotometry and Western blot respectively, while IL-1β levels were measured by solid phase ELISA. Caspase-1 activation was achieved immediately (within 1 h) after hypoxia and persisted for 15 days. IL-1β level was also increased after hypoxia reaching a maximum level at 24 h following hypoxia and returned to baseline by 15 days. Administration of PP2 attenuated the activity acutely, but not the expression of the caspase-1. IL-1β level at 24 h after hypoxia returned to baseline in piglets that were pretreated with PP2. We provide evidence that inhibition of Src kinase in the acute phase after hypoxia involves changes in the production or processing of caspase-1 subunits. Our data suggest that Src kinase mediates hypoxia-induced caspase-1 activation in the cerebral cortex of newborn piglets. Inhibition of Src kinase may attenuate the neuroinflammatory response and could represent a potential target for neuroprotection after hypoxic injury.
authors.affiliation: Department of Pediatrics, St. Christopher's Hospital for Children, Drexel University College of Medicine, 160 East Erie Ave, Philadelphia, PA, 19134, USA, d_agelis@hotmail.com.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Angelis
authors.forename: Tania D
authors.initials: TD
authors.lastname: Fontánez-Nieves
authors.forename: Maria
authors.initials: M
authors.lastname: Delivoria-Papadopoulos
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000378:metabolism*; D020170:Caspase 1 / Q000378:metabolism*; D004195:Disease Models, Animal; D004789:Enzyme Activation / Q000502:physiology; D005260:Female; D002534:Hypoxia, Brain / Q000378:metabolism*; D008297:Male; D015398:Signal Transduction; D013552:Swine; D015854:Up-Regulation / Q000502:physiology; D019061:src-Family Kinases / Q000378:metabolism*
chemical_list: D019061:src-Family Kinases; D020170:Caspase 1
references.citation: J Exp Med. 1997 Feb 17;185(4):601-7
references.pmid: 9034139
references.citation: Nature. 1992 Apr 30;356(6372):768-74
references.pmid: 1574116
references.citation: J Cereb Blood Flow Metab. 1999 Oct;19(10):1099-108
references.pmid: 10532634
references.citation: J Immunol. 1986 Dec 1;137(11):3644-8
references.pmid: 3491144
references.citation: CNS Neurosci Ther. 2012 Sep;18(9):754-61
references.pmid: 22709448
references.citation: Nat Med. 2007 Jul;13(7):851-6
references.pmid: 17572686
references.citation: Biochem Pharmacol. 2000 Oct 1;60(7):885-98
references.pmid: 10974196
references.citation: J Neurochem. 1992 Jan;58(1):390-2
references.pmid: 1727445
references.citation: EMBO J. 2006 May 3;25(9):1895-905
references.pmid: 16619028
references.citation: PLoS One. 2012;7(5):e36422
references.pmid: 22567156
references.citation: Clin Sci (Lond). 2005 Mar;108(3):205-13
references.pmid: 15540988
references.citation: Neurobiol Dis. 2013 Mar;51:113-9
references.pmid: 23127881
references.citation: Early Hum Dev. 1982 Jan;6(1):99-107
references.pmid: 6799270
references.citation: J Biol Chem. 1996 May 31;271(22):13273-82
references.pmid: 8662843
references.citation: J Biol Chem. 2008 Feb 29;283(9):5402-13
references.pmid: 18086677
references.citation: Brain Res Mol Brain Res. 2003 Jun 10;114(2):107-14
references.pmid: 12829320
references.citation: Biochem J. 2007 Dec 15;408(3):297-315
references.pmid: 17850214
references.citation: J Immunol. 2013 Nov 1;191(9):4789-803
references.pmid: 24078693
references.citation: Nature. 1994 May 19;369(6477):233-5
references.pmid: 7514272
references.citation: J Biol Chem. 2000 Aug 18;275(33):25130-8
references.pmid: 10833514
references.citation: Neurotox Res. 2012 Apr;21(3):309-16
references.pmid: 22006118
references.citation: Ann Neurol. 2008 May;63(5):632-41
references.pmid: 18384166
references.citation: J Cereb Blood Flow Metab. 2004 Dec;24(12):1333-51
references.pmid: 15625408
references.citation: Neuroscience. 2000;95(4):1157-65
references.pmid: 10682722
references.citation: ACS Chem Biol. 2012 Aug 17;7(8):1393-8
references.pmid: 22594480
references.citation: Cell Metab. 2005 Jun;1(6):401-8
references.pmid: 16054089
references.citation: Mol Cell Biol. 2004 Sep;24(17):7578-97
references.pmid: 15314167
references.citation: J Cell Sci. 2012 Mar 1;125(Pt 5):1329-41
references.pmid: 22303001
references.citation: Nat Cell Biol. 2011 Dec 04;14(1):51-60
references.pmid: 22138575
references.citation: Eur J Immunol. 2011 May;41(5):1196-202
references.pmid: 21469137
references.citation: J Biol Chem. 2000 May 12;275(19):14248-54
references.pmid: 10799503
references.citation: Biochim Biophys Acta. 2007 Aug;1773(8):1358-75
references.pmid: 17481747
references.citation: Neurosci Lett. 1999 Mar 19;263(1):72-6
references.pmid: 10218914
references.citation: Neurosci Lett. 2010 Aug 9;480(1):35-9
references.pmid: 20570712
references.citation: Cell Mol Neurobiol. 2003 Oct;23(4-5):561-78
references.pmid: 14514016
references.citation: Hum Immunol. 2014 Feb;75(2):134-40
references.pmid: 24269698
references.citation: J Immunol. 1994 Sep 15;153(6):2592-9
references.pmid: 8077669
references.citation: Prog Neurobiol. 2002 Jun;67(2):161-72
references.pmid: 12126659
references.citation: Nature. 2011 Jan 13;469(7329):221-5
references.pmid: 21124315
references.citation: J Interferon Cytokine Res. 1995 Mar;15(3):243-8
references.pmid: 7584670
references.citation: Nat Rev Neurosci. 2004 Apr;5(4):317-28
references.pmid: 15034556
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713
references.citation: Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9833-8
references.pmid: 8790417
references.citation: Mol Cell Biol. 1997 Aug;17(8):4633-43
references.pmid: 9234720
references.citation: Neurosci Lett. 1996 Mar 15;206(2-3):149-52
references.pmid: 8710173
references.citation: J Neurochem. 2004 Mar;88(5):1127-39
references.pmid: 15009668
references.citation: Neurosci Lett. 2009 Aug 21;460(1):61-5
references.pmid: 19463892